The National Cancer Society Malaysia (NCSM) has issued an urgent call for a coordinated national screening framework to combat the accelerating prevalence of cardio-renal-metabolic diseases, which combine heart and kidney conditions with metabolic disorders like diabetes. The warning comes as evidence increasingly demonstrates that these seemingly separate ailments are deeply interconnected, share overlapping risk factors, and systematically compound one another's severity when left undetected and unmanaged in isolation.
Findings from a substantial community screening initiative prove the scale of the challenge facing Malaysian public health authorities. The NCSM-Boehringer Ingelheim Saring@Komuniti Project, conducted with Ministry of Health backing, assessed 5,000 residents from economically disadvantaged areas across the Klang Valley throughout the previous year. The results painted a sobering picture: nearly nine in ten participants displayed at least one cardio-renal-metabolic risk factor, while the vast majority exhibited multiple simultaneous vulnerabilities to these interconnected chronic diseases.
The screening data reveals a nation grappling with profound metabolic dysfunction. Among the cohort surveyed, 41.3 per cent met clinical obesity thresholds, while an additional 28.8 per cent registered as overweight, combining to affect seven in ten participants. Blood sugar disorders emerged as a particularly pressing concern, with 34.5 per cent showing pre-diabetic indicators and 35.1 per cent already diagnosed with diabetes. These figures indicate a substantial reservoir of undiagnosed or inadequately managed metabolic disease circulating within Malaysia's population, suggesting current detection mechanisms are failing to identify at-risk individuals before serious complications develop.
The epidemiological trajectory of chronic kidney disease exemplifies how these conditions have escalated beyond existing healthcare infrastructure capacity. Prevalence rates climbed from 9.1 per cent in 2011 to 15.5 per cent by 2019, a seventy-point increase in less than a decade. Most strikingly, the number of Malaysians dependent on dialysis has more than tripled over two decades, placing enormous strain on both hospital dialysis units and household finances, as families navigate the burdens of long-term renal replacement therapy.
A fundamental structural problem undermines current approaches to these diseases: Malaysian healthcare institutions typically address cardiovascular, kidney, and metabolic conditions through separate clinical pathways and specialist silos. This fragmentation creates dangerous blind spots where patients with multiple concurrent conditions slip through gaps in the system. A person presenting with hypertension might receive cardiac assessment without simultaneous evaluation of kidney function or glucose metabolism, missing critical opportunities to identify dangerous risk factor clustering and initiate preventive intervention before irreversible organ damage occurs.
The consequences of this compartmentalised approach extend beyond initial screening failures. Patients diagnosed through fragmented referral channels frequently encounter inconsistent follow-up protocols, inadequate coordination between specialists, and barriers to sustained engagement with treatment regimens. An abnormal screening result may trigger referral, but structural obstacles often prevent timely specialist consultation, diagnostic confirmation, and the establishment of continuous long-term management necessary for these chronic conditions. This discontinuity proves particularly damaging in underserved communities where transportation difficulties, work constraints, and healthcare literacy challenges already complicate disease management.
NCSM's policy recommendations address these systemic deficiencies through two interconnected strategic priorities. First, Malaysia must expand integrated co-screening programmes capable of simultaneously assessing cardiovascular, renal, and metabolic status rather than evaluating each domain separately. Second, the healthcare system requires fundamental redesign to establish continuous care pathways that reliably shepherd patients from initial screening detection through diagnosis, therapeutic intervention, and sustained long-term management without gaps or discontinuities.
Implementing these recommendations requires embedding standardised cardio-renal-metabolic risk assessments into routine health encounters, transforming what are currently isolated check-ups into comprehensive opportunities for integrated disease detection. Nationwide expansion of coordinated screening programmes would necessitate training additional healthcare workers, developing electronic information systems enabling seamless communication between primary care and specialist services, and establishing accountability mechanisms ensuring diagnosed patients receive timely follow-up appointments and treatment initiation.
Dr Murallitharan Munisamy, Managing Director of NCSM, articulated the strategic imperative: Malaysia possesses a genuine opportunity to transition from managing individual diseases in fragmented isolation toward addressing cardiovascular, kidney, and metabolic health as an integrated continuum. However, this transformation requires that early detection capabilities are matched by coordinated follow-up systems and structured long-term care engagement if Malaysia hopes to improve clinical outcomes and arrest the spiralling burden of chronic disease that increasingly constrains both individual wellbeing and healthcare system capacity.
The economic implications of inaction are substantial. Chronic kidney disease alone generates enormous costs through dialysis provision, medication, hospitalisation, and lost productivity. Uncontrolled diabetes compounds these expenses through cardiovascular complications, blindness, amputation, and accelerated kidney failure. An integrated approach preventing disease progression before advanced stages require intensive intervention offers far superior economic value compared to current reactive management of established conditions. For Malaysia, particularly as its ageing population expands the absolute numbers requiring chronic disease management, prevention-focused integrated screening represents essential policy infrastructure rather than optional enhancement.
Boehringer Ingelheim's involvement in supporting research demonstrating disease interconnection underscores growing pharmaceutical and healthcare sector recognition that traditional disease-specific treatment paradigms inadequately address modern chronic disease complexity. As healthcare systems globally grapple with managing increasingly prevalent comorbidity clusters, Malaysia's policy response will establish precedent influencing how other Southeast Asian nations structure chronic disease prevention and management frameworks. The policy briefs launched by NCSM therefore carry significance extending beyond Malaysia's borders into regional health policy discourse.
The window for implementing such transformative policy changes remains open, though narrowing. Each year Malaysia delays establishing integrated cardio-renal-metabolic screening and management systems perpetuates missed opportunities for early intervention among millions of citizens already displaying dangerous risk factor combinations. Healthcare experts consistently warn that without decisive action implementing coordinated detection and care continuum strengthening, the escalating burden on patients, families, and institutions will continue accelerating beyond manageable levels.
